Staar Prepares For Visian ICL Launch Following Long-Awaited FDA Approval
This article was originally published in The Gray Sheet
Executive Summary
Staar Surgical will target the three million U.S. patients with severe myopia as it rolls out its Visian ICL implantable contact lens after announcing long-awaited PMA approval Dec. 23
You may also be interested in...
FDA Issues Resolved, Staar Shoots For Stronger Sales Of Cataract Products
Staar Surgical is committed to restoring domestic cataract product sales in 2006 after putting its regulatory woes to rest during the fourth quarter
FDA Issues Resolved, Staar Shoots For Stronger Sales Of Cataract Products
Staar Surgical is committed to restoring domestic cataract product sales in 2006 after putting its regulatory woes to rest during the fourth quarter
Staar Will Respond To FDA On “Serious, Continuing Violations”
Staar Surgical said it would issue a report to FDA July 15 detailing the firm's plans for resolving a series of quality systems violations